PRESIDENT, DRUG DEV SOLUTIONS
Mon, Oct 7, 2024
Oct 7
5,409 shares @ $11.03
Decreased holdings by -9.70%
9th largest trade (out of 26)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 29% below 200-day moving average
Small Cap stock — insider trades carry more weight